Trials / Completed
CompletedNCT01362387
R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 999 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Purpose: This randomised trial will compare outcomes and acceptability of an alternative medical abortion follow-up protocol using standardised text messaging, on-line questionnaire, or a phone interview and a low sensitivity pregnancy test with the current standard of care which consists of either a clinic visit and ultrasound scan or a telephone call and high sensitivity pregnancy test. Hypothesis: The use of "alternative" methods to assess outcomes after early medical abortion will achieve a higher rate of follow-up than women undergoing "standard" follow-up Primary aim: To determine the follow-up rate after early medical abortion with an alternative protocol as compared to a standard follow-up protocol Secondary aims: * To assess complication rates and receipt of further treatment among women in the two study arms * To ascertain women's preferences for mode of communication regarding their post-medical abortion status * To determine provider opinions and preferences for different follow-up modalities
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alternative follow-up protocol | Women (n=1000) will be allocated by chance to one of two groups: alternative follow-up using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test, or standard follow-up which consists of an in person visit with an ultrasound or a telephone call and high sensitivity pregnancy test. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-05-30
- Last updated
- 2013-02-15
Locations
4 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01362387. Inclusion in this directory is not an endorsement.